Laurie Kelliher

Laurie Kelliher is an accomplished professional in regulatory affairs with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Executive Director of Regulatory Affairs at CRISPR Therapeutics since September 2019, Laurie previously held senior roles at Emergent BioSolutions as Senior Director of Regulatory Affairs and at AstraZeneca as Global Head of Regulatory Documentation Management. Laurie's tenure at MedImmune included various leadership positions within Global Regulatory Affairs and CMC Regulatory Affairs, demonstrating a strong background in regulatory project management. Early career experience includes a role in Regulatory Affairs at Quintiles. Laurie Kelliher is an alumnus of Bloomsburg University of Pennsylvania.